Ionis Pharma (NASDAQ: IONS) reported Q1 EPS of ($0.52), $0.02 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $36.21 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.